AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS RCEL 深 滬
已收盤 09-05 16:00:00 美东时间
4.26
-0.030
-0.70%
華盛通- 最 高4.4302
- 今 開4.30
- 成交量 25.99万股
- 最 低 4.21
- 昨 收 4.29
- 總市值 1.13亿
- 52周最高 14.16
- 市盈率 靜 --
- 換手率 0.98%
- 52周最低 3.60
- 委 比 0.41%
- 總股本 2643.47万
- 歷史最高 49.11
- 量 比 1.32
- 振 幅 5.13%
- 歷史最低 3.60
- 每 手 1
- 風險率 3.14%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多AVITA Medical Reaffirms RECELL System Reduces Burn Patient LOS By 36%; More Discharged Home Vs. STSG
Analysis of U.S. national burn registry data demonstrates 36% shorter hospital stays in adults with deep second-degree burns treated with RECELL versus traditional skin grafting More than $42,000 per patient cost
09-04 19:51
Real-World Data Shows Significant Reduction in Hospital Stay Using AVITA Medical’s RECELL® System
AVITA Medical's study shows that the RECELL® System reduces hospital stays by 36% for adults with deep second-degree burns, saving over $42,000 per patient and improving hospital efficiency. Presented at the 2025 European Burn Association Congress in Berlin, the research highlights RECELL's clinical and economic benefits in modern burn management.
09-04 11:45
AVITA Medical Announces September Investor Conference Participation
AVITA Medical announced that senior management will participate in three investor conferences in September 2025. The events include the Cantor Global Healthcare Conference on September 4 with CFO David O’Toole, the Morgan Stanley Global Healthcare Conference on September 8 with CEO Jim Corbett, and the Lake Street Capital Markets Best Ideas Growth Conference on September 11 with CFO David O’Toole. A live audio webcast of the Morgan Stanley firesi...
08-21 20:05
Avita Medical Announces $15M Equity Placement Agreement
An announcement from Avita Medical ( ($RCEL) ) is now available. On August 12, ...
08-19 05:52
AVITA Medical Successfully Completes Australian Equity Raise
AVITA Medical, Inc. successfully completed a private placement to raise approximately US$15 million via issuing 17.2 million New CDIs at A$1.32 each. The funds will support the company's therapeutic acute wound portfolio growth and operational flexibility until 2026. The placement reflects strong investor confidence and includes both new and existing Australian shareholders. The New CDIs are expected to begin trading on the ASX on August 20, 2025...
08-12 12:30
AVITA Medical to Host Investor Webinar Briefing
AVITA Medical invites shareholders and investors to an investor webinar on August 14, 2025, at 9 AM AEDT (August 13 at 4 PM PDT). The webinar will cover Q2 2025 financial and business results, with a Q&A session. Register at [link]. AVITA, a leader in acute wound care, highlights its FDA-approved RECELL System for burn and trauma wound treatment, along with other products like PermeaDerm and Cohealyx. A replay will be available post-event. For mo...
08-10 23:00
D. Boral Capital Maintains Buy on AVITA Medical, Lowers Price Target to $18
D. Boral Capital analyst Jason Kolbert maintains AVITA Medical (NASDAQ:RCEL) with a Buy and lowers the price target from $19 to $18.
08-08 20:26
Avita Medical Amends Credit Agreement with OrbiMed
An announcement from Avita Medical ( ($RCEL) ) is now available. On August 7, 2...
08-08 05:43
AVITA Medical Q2 EPS $(0.38) Misses $(0.25) Estimate, Sales $18.42M Miss $22.61M Estimate
AVITA Medical (NASDAQ:RCEL) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of $(0.25) by 53.23 percent. This is a 36.67 percent increase over losses of $(0.60) per share from
08-08 04:09
Here are the major earnings after the close Thursday
Major earnings expected after the bell on Thursday include: Block (XYZ) Gilead Sciences (GILD) Twilio (TWLO) The Trade Desk (TTD) Main Street Capital Corporation (MAIN) Other earnings slated for rele...
08-07 22:00
